BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 2169656)

  • 1. Massive tissue necrosis can be induced by heparin or warfarin.
    Ritchie AJ; Hart NB
    Ulster Med J; 1991 Oct; 60(2):248-50. PubMed ID: 1785165
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
    España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
    Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
    Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
    Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
    Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
    Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
    Chan AK; Patel S; Male C; Berry LR; Mitchell LG
    Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
    Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
    Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein C, protein S and heparin cofactor II--their significance as the regulatory factors in the blood coagulation cascade].
    Shinmyozu K
    Rinsho Byori; 1994 Jan; 42(1):9-15. PubMed ID: 8107289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C inhibitor.
    Meijers JC; Herwald H
    Semin Thromb Hemost; 2011 Jun; 37(4):349-54. PubMed ID: 21805440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activated protein C-protein C inhibitor complex (APC-PCI complex)].
    Nishioka J; Suzuki K
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():125-9. PubMed ID: 8753198
    [No Abstract]   [Full Text] [Related]  

  • 12. PCI: protein C inhibitor?
    Cooper ST; Church FC
    Adv Exp Med Biol; 1997; 425():45-54. PubMed ID: 9433488
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.